Dutta, R, Boydell, J, Kennedy, N, van Os, J, Fearon, P, Murray, RM. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychol Med
2007; 37: 839–47.
Lloyd, T, Kennedy, N, Fearon, P, Kirkbride, J, Mallett, R, Leff, J, et al. Incidence of bipolar affective disorder in three UK cities: results from the AESOP study. Br J Psychiatry
2005; 186: 126–31.
Le-Niculescu, H, Kurian, SM, Yehyawi, N, Dike, C, Patel, SD, Edenberg, HJ, et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry
2009; 14: 156–74.
Duman, RS, Malberg, J, Nakagawa, S, D'Sa, C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry
2000; 48: 732–9.
Einat, H, Manji, HK. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry
2006; 59: 1160–71.
Dunham, JS, Deakin, JF, Miyajima, F, Payton, A, Toro, CT. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains. J Psychiatr Res
2009; 43: 1175–84.
Rajkowska, G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry
2000; 48: 766–77.
Fernandes, BS, Gama, CS, Ceresér, KM, Yatham, LN, Fries, GR, Colpo, G, et al. Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: A systematic review and meta-regression analysis. J Psychiatr Res
2011; 45: 995–1004.
Fukumoto, T, Morinobu, S, Okamoto, Y, Kagaya, A, Yamawaki, S. Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl)
2001; 158: 100–6.
Frey, BN, Andreazza, AC, Cereser, KM, Martins, MR, Valvassori, SS, Réus, GZ, et al. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania. Life Sci
2006; 79: 281–6.
Brunoni, AR, Lopes, M, Fregni, F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol
2008; 11: 1169–80.
D'Sa, C, Duman, RS. Antidepressants and neuroplasticity. Bipolar Disord
2002; 4: 183–94.
Kelleher, RJ, Govindarajan, A, Tonegawa, S. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron
2004; 44: 59–73.
First, MB, Spitzer, R, Gibbon, M, Williams, JBW. Structured Clinical Interview for DSM–IV Axis I Disorders. . Biometrics Research Department, New York State Psychiatric Institute, 1995.
Hamilton, M. A rating scale for depression. J Neurol Neurosurg Psychiatry
1960; 23: 56–62.
Young, RC, Biggs, JT, Ziegler, VE, Meyer, DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry
1978; 133: 429–35.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th edn) . APA, 1994.
Narisawa-Saito, M, Nawa, H. Differential regulation of hippocampal neurotrophins during aging in rats. J Neurochem
1996; 67: 1124–31.
Pillai, A, Bruno, D, Sarreal, AS, Hernando, RT, Saint-Louis, LA, Nierenberg, J, et al. Plasma BDNF levels vary in relation to body weight in females. PLoS One
2012; 7: e39358.
Zhang, H, Singer, B. Recursive Partitioning in the Health Sciences.
Breiman, L, Friedman, JH, Olshen, RA, Stone, CJ. Classification and Regression Trees.
Hosmer, DW, Lemeshow, S. Applied Logistic Regression (2nd edn). Wiley-Interscience, 2000.
World Health Organization. Prevention of Mental Disorders: Effective Interventions and Policy Options.
Grande, I, Fries, GR, Kunz, M, Kapczinski, F. The role of BDNF as a mediator of neuroplasticity in bipolar disorder. Psychiatry Investig
2010; 7: 243–50.
Gu, L, Xie, J, Long, J, Chen, Q, Chen, Q, Pan, R, et al. Epidemiology of major depressive disorder in mainland China: a systematic review. PLoS One
2013; 8: e65356.
de Oliveira, GS, Cereser, KM, Fernandes, B, Kauer-Sant'anna, M, Fries, GR, Stertz, L, et al. Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients. J Psychiatr Res
2009; 43: 1171–4.
Fernandes, BS, Gama, CS, Kauer-Sant'Anna, M, Lobato, MI, Belmonte-de-Abreu, P, Kapczinski, F. Serum brain-derived neurotrophic factor in bipolar and unipolar depression: a potential adjunctive tool for differential diagnosis. J Psychiatr Res
2009; 43: 1200–4.
Machado-Vieira, R, Dietrich, MO, Leke, R, Cereser, VH, Zanatto, V, Kapczinski, F, et al. Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode. Biol Psychiatry
2007; 61: 142–4.
Mackin, P, Gallagher, P, Watson, S, Young, AH, Ferrier, IN. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. Aust NZ J Psychiatry
2007; 41: 321–6.
Sen, S, Duman, R, Sanacora, G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry
2008; 64: 527–32.
Blugeot, A, Rivat, C, Bouvier, E, Molet, J, Mouchard, A, Zeau, B, et al. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci
2011; 31: 12889–99.
Taylor, SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT
2008; 24: 160–5.
Arnone, D, McKie, S, Elliott, R, Juhasz, G, Thomas, EJ, Downey, D, et al. State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry
2013; 18: 1265–72.
Cubeddu, A, Bucci, F, Giannini, A, Russo, M, Daino, D, Russo, N, et al. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome. Psychoneuroendocrinology
2011; 36: 523–30.
Nakazato, M, Tchanturia, K, Schmidt, U, Campbell, IC, Treasure, J, Collier, DA, et al. Brain-derived neurotrophic factor (BDNF) and set-shifting in currently ill and recovered anorexia nervosa (AN) patients. Psychol Med
2009; 39: 1029–35.
Li, Z, Qi, D, Chen, J, Zhang, C, Yi, Z, Yuan, C, et al. Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in Chinese patients with major depressive disorder: A prospective longitudinal study. Psychoneuroendocrinology
2013; 38: 107–14.
Jacobsen, JP, Mork, A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res
2004; 1024: 183–92.
Omata, N, Murata, T, Takamatsu, S, Maruoka, N, Mitsuya, H, Yonekura, Y, et al. Neuroprotective effect of chronic lithium treatment against hypoxia in specific brain regions with upregulation of cAMP response element binding protein and brain-derived neurotrophic factor but not nerve growth factor: comparison with acute lithium treatment. Bipolar Disord
2008; 10: 360–8.
Arnone, D, McIntosh, AM, Ebmeier, KP, Munafò, MR, Anderson, IM. Magnetic resonance imaging studies in unipolar depression: systematic review and meta-regression analyses. Eur Neuropharmacology
2012; 22: 1–16.
Arnone, D, Cavanagh, J, Gerber, D, Lawrie, SM, Ebmeier, KP, McIntosh, AM. Magnetic resonance imaging studies in bipolar disorder and schizophrenia: meta-analysis. Br J Psychiatry
2009; 195: 194–201.
Kempton, MJ, Geddes, JR, Ettinger, U, Williams, SC, Grasby, PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry
2008; 65: 1017–32.